LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 319

Search options

  1. Article ; Online: Contribution of S100A4-expressing fibroblasts to anti-SSA/Ro-associated atrioventricular nodal calcification and soluble S100A4 as a biomarker of clinical severity.

    Firl, Christina E M / Halushka, Marc / Fraser, Nicola / Masson, Mala / Cuneo, Bettina F / Saxena, Amit / Clancy, Robert / Buyon, Jill

    Frontiers in immunology

    2023  Volume 14, Page(s) 1114808

    Abstract: Background: Fibrosis and dystrophic calcification disrupting conduction tissue architecture are histopathological lesions characterizing cardiac manifestations of neonatal lupus (cardiac-NL) associated with maternal anti-SSA/Ro antibodies.: Objectives! ...

    Abstract Background: Fibrosis and dystrophic calcification disrupting conduction tissue architecture are histopathological lesions characterizing cardiac manifestations of neonatal lupus (cardiac-NL) associated with maternal anti-SSA/Ro antibodies.
    Objectives: Increased appreciation of heterogeneity in fibroblasts encourages re-examination of existing models with the consideration of multiple fibroblast subtypes (and their unique functional differences) in mind. This study addressed fibroblast heterogeneity by examining expression of α-Smooth Muscle Actin (myofibroblasts) and of S100 Calcium-Binding Protein A4 (S100A4).
    Methods: Using a previously established model of rheumatic scarring/fibrosis
    Results: S100A4 immunostaining was observed in 4 cardiac-NL hearts with positional identity in the conduction system at regions of dystrophic calcification but not fibrotic zones, the latter containing only myofibroblasts.
    Conclusions: These findings position the S100A4
    MeSH term(s) Infant, Newborn ; Humans ; Heart Block/etiology ; Heart Block/pathology ; Heart ; Biomarkers ; Calcinosis ; Fibrosis ; Fibroblasts/metabolism ; S100 Calcium-Binding Protein A4/metabolism
    Chemical Substances Biomarkers ; S100A4 protein, human (142662-27-9) ; S100 Calcium-Binding Protein A4
    Language English
    Publishing date 2023-04-06
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1114808
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The quality and content of hyperthermic intraperitoneal chemotherapy information available to patients: An evaluation of North American hyperthermic intraperitoneal chemotherapy websites.

    Remer, Sarah L / Connelly, Tara M / Clancy, Cillian / DeBernardo, Robert / Joyce, Daniel / Steele, Scott R / Valente, Michael A

    Surgery

    2023  Volume 174, Issue 1, Page(s) 30–35

    Abstract: Background: Patients commonly use the internet to obtain medical information. Patients in our outpatient setting frequently have incomplete or even incorrect information about hyperthermic intraperitoneal chemotherapy that they have found on the ... ...

    Abstract Background: Patients commonly use the internet to obtain medical information. Patients in our outpatient setting frequently have incomplete or even incorrect information about hyperthermic intraperitoneal chemotherapy that they have found on the internet. We aimed to assess the quality and content of Web-based information on hyperthermic intraperitoneal chemotherapy using validated and novel scoring systems.
    Methods: The keywords "HIPEC" and "hyperthermic intraperitoneal chemotherapy" were entered into the most commonly used internet search engines (Google, Bing, and Yahoo). The first 10 websites from each search were analyzed. Website quality was assessed using the validated Journal of the American Medical Association benchmark criteria and DISCERN scoring systems. We created a novel hyperthermic intraperitoneal chemotherapy-specific score with surgeon experts in the field.
    Results: Eighteen unique websites were identified. The majority (78%) were from academic institutions. The mean total DISCERN score for all websites was 41.8 ± 8.4 (maximum possible points = 75). The mean Journal of the American Medical Association and hyperthermic intraperitoneal chemotherapy-specific scores were 1.72 ± 1.13 (maximum possible score = 4) and 11.5 ± 4.5 (maximum possible score = 31), respectively. The lowest Journal of the American Medical Association scores were in the category of authorship. In total, 78% of websites omitted author details; 83% and 78% included the temperature and duration of hyperthermic intraperitoneal chemotherapy, respectively. Only 39% of websites mentioned complications of hyperthermic intraperitoneal chemotherapy.
    Conclusion: Web-based information on hyperthermic intraperitoneal chemotherapy is of variable content and quality. None of the websites achieved maximum scores using any of the scoring tools. Less than half of the websites provided any information on possible complications of the procedure. These findings should be highlighted to patients using the internet to obtain information about hyperthermic intraperitoneal chemotherapy.
    MeSH term(s) Humans ; Search Engine ; Internet ; Outpatients ; North America ; Comprehension ; Consumer Health Information
    Language English
    Publishing date 2023-05-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 202467-6
    ISSN 1532-7361 ; 0039-6060
    ISSN (online) 1532-7361
    ISSN 0039-6060
    DOI 10.1016/j.surg.2023.03.025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus.

    Blazer, Ashira D / Clancy, Robert M

    Current rheumatology reports

    2017  Volume 19, Issue 3, Page(s) 13

    Abstract: Purpose of review: Systemic lupus erythematosus (SLE) confers up to a 50-fold increased risk of cardiovascular disease (CVD), and African Americans with SLE experience accelerated damage accrual and doubled cardiovascular risk when compared to their ... ...

    Abstract Purpose of review: Systemic lupus erythematosus (SLE) confers up to a 50-fold increased risk of cardiovascular disease (CVD), and African Americans with SLE experience accelerated damage accrual and doubled cardiovascular risk when compared to their European American counterparts.
    Recent findings: Genome-wide association studies have identified a substantial signal at 22q13, now assigned to variation at apolipoprotein L1 (APOL1), which has associated with progressive nondiabetic nephropathy, cardiovascular disease, and many immune-associated renal diseases, including lupus nephritis. We contend that alterations in crucial APOL1 intracellular pathways may underpin associated disease states based on structure-functional differences between variant and ancestral forms. While ancestral APOL1 may be a key driver of autophagy, nonconserved primary structure changes result in a toxic gain of function with attenuation of autophagy and an unsupervised pore-forming feature. Thus, the divergent intracellular biological pathways of ancestral and variant APOL1 may explain a worsened prognosis as demonstrated in SLE.
    MeSH term(s) Apolipoprotein L1 ; Apolipoproteins/genetics ; Apolipoproteins/physiology ; Autophagy/genetics ; Cardiovascular Diseases/genetics ; Cardiovascular Diseases/immunology ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Humans ; Lipoproteins, HDL/genetics ; Lipoproteins, HDL/physiology ; Lupus Erythematosus, Systemic/genetics ; Lupus Erythematosus, Systemic/immunology ; Lupus Nephritis/genetics ; Lupus Nephritis/immunology
    Chemical Substances APOL1 protein, human ; Apolipoprotein L1 ; Apolipoproteins ; Lipoproteins, HDL
    Language English
    Publishing date 2017-03-13
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2057357-1
    ISSN 1534-6307 ; 1523-3774
    ISSN (online) 1534-6307
    ISSN 1523-3774
    DOI 10.1007/s11926-017-0637-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Reply.

    Buyon, Jill / Izmirly, Peter / Masson, Mala / Carlucci, Philip / Izmirly, Caroline G / Clancy, Robert / Cuneo, Bettina

    Arthritis & rheumatology (Hoboken, N.J.)

    2024  

    Language English
    Publishing date 2024-01-17
    Publishing country United States
    Document type Letter
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.42806
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).

    Alkhalid, Yasmine / Darji, Zeena / Shenkar, Robert / Clancy, Marianne / Dyamenahalli, Umesh / Awad, Issam A

    Vascular medicine (London, England)

    2023  Volume 28, Issue 2, Page(s) 153–165

    Abstract: Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is a rare disorder with a case prevalence as high as one in 5000, causing arteriovenous malformations in multiple organ systems. HHT is familial with autosomal dominant ...

    Abstract Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is a rare disorder with a case prevalence as high as one in 5000, causing arteriovenous malformations in multiple organ systems. HHT is familial with autosomal dominant inheritance, with genetic testing allowing confirmation of the diagnosis in asymptomatic kindreds. Common clinical manifestations are epistaxis and intestinal lesions causing anemia and requiring transfusions. Pulmonary vascular malformations predispose to ischemic stroke and brain abscess and may cause dyspnea and cardiac failure. Brain vascular malformations can cause hemorrhagic stroke and seizures. Rarely, liver arteriovenous malformations can cause hepatic failure. A form of HHT can cause juvenile polyposis syndrome and colon cancer. Specialists in multiple fields may be called to care for one or more aspects of HHT, but few are familiar with evidence-based guidelines for HHT management or see a sufficient number of patients to gain experience with the unique characteristics of the disease. Primary care physicians and specialists are often unaware of the important manifestations of HHT in multiple systems and the thresholds for their screening and appropriate management. To improve familiarity, experience, and coordinated multisystem care for patients with HHT, the Cure HHT Foundation, which advocates for patients and families with this disease, has accredited 29 centers in North America with designated specialists for the evaluation and care of patients with HHT. Team assembly and current screening and management protocols are described as a model for evidence-based, multidisciplinary care in this disease.
    MeSH term(s) Humans ; Telangiectasia, Hereditary Hemorrhagic/diagnosis ; Telangiectasia, Hereditary Hemorrhagic/genetics ; Telangiectasia, Hereditary Hemorrhagic/therapy ; Arteriovenous Malformations/diagnostic imaging ; Arteriovenous Malformations/therapy ; Lung ; Central Nervous System Vascular Malformations ; Prevalence
    Language English
    Publishing date 2023-03-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 1311628-9
    ISSN 1477-0377 ; 1358-863X
    ISSN (online) 1477-0377
    ISSN 1358-863X
    DOI 10.1177/1358863X231151731
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Efficient in planta production of amidated antimicrobial peptides that are active against drug-resistant ESKAPE pathogens.

    Chaudhary, Shahid / Ali, Zahir / Tehseen, Muhammad / Haney, Evan F / Pantoja-Angles, Aarón / Alshehri, Salwa / Wang, Tiannyu / Clancy, Gerard J / Ayach, Maya / Hauser, Charlotte / Hong, Pei-Ying / Hamdan, Samir M / Hancock, Robert E W / Mahfouz, Magdy

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 1464

    Abstract: Antimicrobial peptides (AMPs) are promising next-generation antibiotics that can be used to combat drug-resistant pathogens. However, the high cost involved in AMP synthesis and their short plasma half-life render their clinical translation a challenge. ... ...

    Abstract Antimicrobial peptides (AMPs) are promising next-generation antibiotics that can be used to combat drug-resistant pathogens. However, the high cost involved in AMP synthesis and their short plasma half-life render their clinical translation a challenge. To address these shortcomings, we report efficient production of bioactive amidated AMPs by transient expression of glycine-extended AMPs in Nicotiana benthamiana line expressing the mammalian enzyme peptidylglycine α-amidating mono-oxygenase (PAM). Cationic AMPs accumulate to substantial levels in PAM transgenic plants compare to nontransgenic N. benthamiana. Moreover, AMPs purified from plants exhibit robust killing activity against six highly virulent and antibiotic resistant ESKAPE pathogens, prevent their biofilm formation, analogous to their synthetic counterparts and synergize with antibiotics. We also perform a base case techno-economic analysis of our platform, demonstrating the potential economic advantages and scalability for industrial use. Taken together, our experimental data and techno-economic analysis demonstrate the potential use of plant chassis for large-scale production of clinical-grade AMPs.
    MeSH term(s) Animals ; Anti-Bacterial Agents/biosynthesis ; Anti-Bacterial Agents/pharmacology ; Antimicrobial Cationic Peptides/biosynthesis ; Antimicrobial Cationic Peptides/pharmacology ; Antimicrobial Peptides/biosynthesis ; Mammals ; Plants ; Nicotiana/chemistry ; Nicotiana/genetics ; Drug Resistance, Bacterial/drug effects
    Chemical Substances Anti-Bacterial Agents ; Antimicrobial Cationic Peptides ; Antimicrobial Peptides
    Language English
    Publishing date 2023-03-16
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-37003-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The modifying influence of HLA class II DQB1∗06:02 on the

    Clancy, Robert M / Guthridge, Carla J / Marion, Miranda C / Guthridge, Joel / Howard, Timothy D / Izmirly, Peter M / Masson, Mala / Buyon, Jill P / James, Judith A / Langefeld, Carl D

    Genes & diseases

    2022  Volume 10, Issue 4, Page(s) 1169–1171

    Language English
    Publishing date 2022-12-13
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2821806-1
    ISSN 2352-3042 ; 2352-3042
    ISSN (online) 2352-3042
    ISSN 2352-3042
    DOI 10.1016/j.gendis.2022.11.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Chronic Exposure to Polystyrene Microplastic Fragments Has No Effect on Honey Bee Survival, but Reduces Feeding Rate and Body Weight.

    Al Naggar, Yahya / Sayes, Christie M / Collom, Clancy / Ayorinde, Taiwo / Qi, Suzhen / El-Seedi, Hesham R / Paxton, Robert J / Wang, Kai

    Toxics

    2023  Volume 11, Issue 2

    Abstract: Microplastics (MPs), in the form of fragments and fibers, were recently found in honey samples collected in Ecuador as well as in honey bees collected from Denmark and China. However, little is known about how MPs impact bee health. To fill this ... ...

    Abstract Microplastics (MPs), in the form of fragments and fibers, were recently found in honey samples collected in Ecuador as well as in honey bees collected from Denmark and China. However, little is known about how MPs impact bee health. To fill this knowledge gap, we investigated the potential toxicity of irregularly shaped polystyrene (PS)-MP fragments on honey bee health. In the first experiment of its kind with honey bees, we chronically exposed bees with a well-established gut microbiome to small (27 ± 17 µm) or large (93 ± 25 µm) PS-MP fragments at varying concentrations (1, 10, 100 µg mL
    Language English
    Publishing date 2023-01-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2733883-6
    ISSN 2305-6304 ; 2305-6304
    ISSN (online) 2305-6304
    ISSN 2305-6304
    DOI 10.3390/toxics11020100
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: APOL1

    Blazer, Ashira / Qian, Yingzhi / Schlegel, Martin Paul / Algasas, Huda / Buyon, Jill P / Cadwell, Ken / Cammer, Michael / Heffron, Sean P / Liang, Feng-Xia / Mehta-Lee, Shilpi / Niewold, Timothy / Rasmussen, Sara E / Clancy, Robert M

    Frontiers in genetics

    2022  Volume 13, Page(s) 769936

    Abstract: Polymorphisms in the Apolipoprotein L1 ( ...

    Abstract Polymorphisms in the Apolipoprotein L1 (
    Language English
    Publishing date 2022-09-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2606823-0
    ISSN 1664-8021
    ISSN 1664-8021
    DOI 10.3389/fgene.2022.769936
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Transplantation of kidneys after normothermic perfusion: A single center experience.

    Pearson, Robert / Geddes, Colin / Mark, Patrick / Clancy, Marc / Asher, John

    Clinical transplantation

    2021  Volume 35, Issue 10, Page(s) e14431

    Abstract: Background: In order to expand the pool of usable donors from circulatory death (DCD) there is increasing interest in normothermic regional perfusion (NRP) to assess and improve liver viability.: Methods: Data was obtained from a prospectively ... ...

    Abstract Background: In order to expand the pool of usable donors from circulatory death (DCD) there is increasing interest in normothermic regional perfusion (NRP) to assess and improve liver viability.
    Methods: Data was obtained from a prospectively maintained database between December 2012 and September 2018. Primary endpoints were incidence of delayed graft function (DGF) and estimated glomerular filtration rate (eGFR).
    Results: Six-hundred and thirty-two decease donor kidneys were transplanted, 229 from DCD donors, 29 of which had NRP. The DGF rate was lower for NRP versus DCD (six of 29, 20.7% vs. 70 of 200, 35.0%) with reduced duration of DGF. Multivariate analysis demonstrated transplant type to be a statistically significant independent predictor of eGFR at 7 and 14 days. Early transplant function in NRP kidneys was comparable to DBD. There were no graft losses within 30 days in the NRP group. One-year graft loss rate was 3.4% for NRP and 6.0% for standard DCD.
    Conclusion: This data suggests NRP is safe, and reduces rates of DGF and improves early renal transplant function.
    MeSH term(s) Delayed Graft Function/etiology ; Graft Survival ; Humans ; Kidney ; Organ Preservation ; Perfusion ; Tissue Donors
    Language English
    Publishing date 2021-08-03
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 639001-8
    ISSN 1399-0012 ; 0902-0063
    ISSN (online) 1399-0012
    ISSN 0902-0063
    DOI 10.1111/ctr.14431
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top